ClinicalTrials.Veeva

Menu

Hemodynamic Implications of Transcatheter Tricuspid Valve Repair in HFpEF Patients (HERACLES-HFpEF)

H

Heart Center Leipzig - University Hospital

Status

Unknown

Conditions

Tricuspid Regurgitation
Congestive Heart Failure

Treatments

Device: Transcatheter tricuspid valve edge-to-edge repair

Study type

Interventional

Funder types

Other

Identifiers

NCT04782908
HERACLES-HFpEF

Details and patient eligibility

About

The aim of the study is to investigate the pathophysiological implications of transcatheter tricuspid valve edge-to-edge repair in patient with heart failure and preserved ejection fraction and severe tricuspid regurgitation. Changes in right- and left-ventricular function as well as the interventricular dependence will be analysed on a multimodal basis including pressure-volume loop analysis and cardiac magnetic resonance imaging.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Severe tricuspid regurgitation with need for interventional treatment approach as decided by an interdisciplinary heart team.
  • Signs and symptoms of left-sided heart failure.
  • Left-ventricular ejection fraction ≥50%
  • Invasive evidence of elevated left-ventricular fillings pressures (pulmonary capillary wedge pressure [PCWP] or left-ventricular end-diastolic pressure ≥15 mmHg)

Exclusion criteria

  • Concomitant relevant mitral valve regurgitation with need for concomitant interventional treatment
  • Moderate aortic stenosis.
  • Pregnancy
  • Contraindication to perform cardiac magnetic resonance imaging.
  • Conditions rendering patient unable to give informed consent to the study protocol.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Transcatheter tricuspid valve edge-to-edge repair
Experimental group
Description:
Patients will undergo transcatheter tricuspid valve edge-to-edge repair (TTVR) and hemodynamic characteristics will be analysed on a multimodal approach using cardiac magnetic resonance imaging and pressure volume loop analysis before and after TTVR.
Treatment:
Device: Transcatheter tricuspid valve edge-to-edge repair

Trial contacts and locations

1

Loading...

Central trial contact

Philipp Lurz, MD, PhD; Karl-Patrik Kresoja, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems